Sentences with phrase «benefits than other technologies»

Among other points, Mr. Romm says the «fourth generation» form of nuclear power discussed by Dr. Hansen has no greater potential benefits than other technologies (solar - thermal power plants, for example) that were not mentioned but that could be deployed at large scale much more quickly.

Not exact matches

Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

I think its time to do something about this, over the 2 legs, ireland were clearly the better side, that notwithstanding this particular french team is the worst i've seen in decades, and they have no bussines going to the world cup.It is time for replays to be reviewed in some cases and goaline technology to be applied in other cases, i think we human being have come of age to realise that we humans are not perfect, no matter how hard we try, so for sepp blatter to keep resisting replays and goal line technology is quite baffling to me, i can't really understand why 3 socalled officials could make a decision, a decision in which the whole world saw to be a foul, and its allowed to stand, and a nation is left, heartbroken, cheated and bitter, i am an african, but as a fan of football, i felt terrible seeing this, and i beg the question, if someone other than the team is not benefiting from this, why can't the officials be allowed to take a look at the replays in order to officiate the game better?

In this case, the staff realized that tweaking, streamlining and optimizing the details of supporter recruitment and management would yield more concrete benefits than developing any particular piece of gee - whiz new technology — a mantra other online communicators should recite every night before bed.

«When a new technology appears, this country has a history of being the country that takes it to scale and leverages it for economic benefit faster than other countries do.»

The primary benefit to Netflix, Dropbox, the European Space Agency (ESA), Yelp and other customers is that they are paying for exactly the computer resources that they use, whereas many in - house information technology departments are considered efficient if they are using more than 20 percent of their data center resources, Singh says.

It's not necessarily a comfortable reconceptualization — but looking at risk from this new angle does pave the way for technologies that benefit many people and disadvantage few, rather than the other way round.

While technology proliferates in schools today, some is more useful than others and needs to be straightforward to use and offer clear benefits that solve a real problem, as well as being adaptable to an individual school or college and to the changing needs of the education sector.

It's possible in the case of this technology, unlike the other four the Institute analyzed, to establish a somewhat more precise prediction of the safety benefit than the maximum number of relevant crashes.

«Family planning could bring more benefits to more people at less cost than any other single «technology» now available to the human race.

Both will still produce power that is more expensive than coal, but Google believes that this will change with continued investment in the technologies used and with others coming on board as companies begin to realise the benefits to be gained.

«Given its unique and wide ranging benefits including its baseload capability, relative low cost to other generation technologies and that it doesn't produce waste materials that need to be dealt with by future generations, it is vital that governments provide funding and support to develop their geothermal industries equal to, if not greater than, that provided to other technologies,» says Susan Jeanes, Chief Executive of the Australian Geothermal Energy Association.

I wonder if this technology could be used for something other than marketing — to benefit human kind rather than boost consumerism.

Though these and other safety features will certainly keep your family safer, unfortunately they won't lower your insurance rate: our latest research found that despite proven safety benefits, new technology saves drivers less than 1 % a year on their car insurance premiums.

Each Roku player offers different features — some offering more advanced technology and benefits than others.

Other than the standard visual resume, job seekers benefit from the technology of the Internet with two additional types of resumes: electronic and scannable.